ILB

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	4

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03705390 (ClinicalTrials.gov)	March 29, 2019	11/9/2018	A Safety and Tolerability Study of ILB in Patients With Amyothrophic Lateral Sclerosis (ALS)	A Phase II Pilot Single-arm Safety and Tolerability Study of ILBin Patients With Motor Neurone Disea ...	Amyotrophic Lateral Sclerosis;Motor Neuron Disease	Drug: ILB	University of Birmingham	TikoMed AB;University Hospital Birmingham;Neuregenix	Completed	18 Years	N/A	All	11	Phase 2	United Kingdom
2	NCT03613571 (ClinicalTrials.gov)	August 15, 2018	15/6/2018	A Study to Evaluate the Safety, Tolerability and Efficacy of ILBin Patients With Amyotrophic Lateral ...	A Single-centre, Open Single-arm Study Where the Safety, Tolerability and Efficacy of Subcutaneously ...	Amyotrophic Lateral Sclerosis	Drug: ILB	TikoMed AB	NULL	Terminated	18 Years	80 Years	All	13	Phase 2	Sweden
3	EUCTR2018-000668-28-GB (EUCTR)	09/08/2018	25/06/2018	A study to assess safety and acceptability of a treatment in patients with ALS	A Phase II pilot safety and tolerability study of ILBin patients with Motor Neurone Disease (MND)/Am ...	Motor Neurone Disease (MND)/Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Class ...	Product Name: ILB: 100mg/ml solution for injection and infusion INN or Proposed INN: Dextran Sodium S ...	University of Birmingham	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	15	Phase 2	United Kingdom
4	EUCTR2017-005065-47-SE (EUCTR)	15/05/2018	19/03/2018	A single-center, open single-arm study where the safety, tolerability and efficacy of subcutaneously ...	A single-centre, open single-arm study where the safety, tolerability and efficacy of subcutaneously ...	Amyotrophic Lateral Sclerosis (ALS);Therapeutic area: Body processes [G] - Immune system processes [ ...	Product Name: ILB Product Code: ILB INN or Proposed INN: ILB Other descriptive name: DEXTRAN SULFATE SO ...	TikoMed AB	NULL	Not Recruiting			Female: yes Male: yes	15	Phase 2	Sweden

First Previous1Next Last